Abstract: SA-PO1077
Convective Daily Home Dialysis Program Development: Preliminary Outcomes
Session Information
- Home Hemodialysis
November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 702 Dialysis: Home Hemodialysis
Author
- Nicoud, Philippe, Centre de Néphrologie du Mont Blanc, Sallanches, France
Background
Since 2014, 370 ESRD French patients entered a new short daily home dialysis program based on a convective therapy. We present here the primary clinical and biological outcomes of the first 140 patients treated.
Methods
The epidemiological and clinical characteristics of these 140 patients treated with this technique were analyzed after retrospective data collection. Weekly dialysis performance was evaluated according to the standardized Kt/V (SDT) using the Gotch method. Data were collected during the in-center training periods of each patient prior to their final home installation.
Results
The anonymized data of 140 patients in the technique (age: 53 ± 7 y, weight: 74.2 ± 16.5 kg) were collected. Sex ratio: Male 74%; Female 26%. 123 patients (88%), were diabetes type II free and 80 patients (57%) have kept a residual kidney function. 98 patients (70%) had full time job. 228 home daily dialysis sessions were performed between 2014 and 2017, average time 124 ± 12 min per session, 5.8 ± 0.4 sessions per week. Average blood flow was 284 ± 19 mL/min, dialysate flow 181 ± 6 mL/min. Average Convection volume excluding weight loss was 3.040 ± 1.059 mL per session. The urea Kt/V SDT, was greater than 2.1 in 184/215 (86%) sessions (figure) and the average ultrafiltration rate was 8.5 ± 5, 1mL/h/kg.
Conclusion
This work illustrates the clinical and biological profile of the first patients treated with a short daily home dialysis convective technic. It gives the level of performance in terms of urea RR, convective volume achieved and ultrafiltration rate. These results have to be confirmed and refined by a broader multicentric retrospective study, RECAP, currently underway, which include all the ESRD patients entering this technique between January 2014 and June 2018.
Funding
- Commercial Support – PHYSIDIA